Literature DB >> 1709794

Inhibition of transient outward K+ current by DHP Ca2+ antagonists and agonists in rabbit cardiac myocytes.

Y Gotoh1, Y Imaizumi, M Watanabe, E F Shibata, R B Clark, W R Giles.   

Abstract

The 1,4-dihydropyridine (DHP) Ca2+ antagonists and agonists can inhibit a time- and voltage-dependent, but intracellular Ca(2+)-independent transient outward K+ current (It), in myocytes from rabbit atrium. In the presence of 0.3 mM CdCl2, DHPs decreased the peak It slightly and markedly accelerated its apparent rate of inactivation. When the inhibition of It was measured from integrated It records, the 50% inhibitory concentrations (IC50) of nicardipine and BAY K 8644 were 630 nM and 7 microM, respectively, and the IC50 of nicardipine for inhibition of the Ca2+ current (ICa) was only approximately fourfold lower (160 nM). The inhibition of It by nicardipine was not affected by changing holding potential from -55 to -100 mV; in contrast, the inhibitory effect on ICa was significantly reduced by this hyperpolarization. We conclude that the DHP Ca2+ antagonist nicardipine blocks It at similar doses to those that block ICa and that nicardipine blocks this K+ current by mechanism different from that for ICa inhibition. This inhibitory effect on It is shared by other DHP compounds; the rank order for potency of It inhibition is nicardipine greater than benidipine greater than nisoldipine greater than BAY K 8644 greater than nitrendipine greater than nifedipine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709794     DOI: 10.1152/ajpheart.1991.260.5.H1737

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  19 in total

1.  Relationship between transient outward K+ current and Ca2+ influx in rat cardiac myocytes of endo- and epicardial origin.

Authors:  T Volk; T H Nguyen; J H Schultz; H Ehmke
Journal:  J Physiol       Date:  1999-09-15       Impact factor: 5.182

2.  Effects of diltiazem and nifedipine on transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes.

Authors:  Zhan Gao; Haiying Sun; Shui-Wah Chiu; Chu-Pak Lau; Gui-Rong Li
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

3.  Dihydropyridine action on voltage-dependent potassium channels expressed in Xenopus oocytes.

Authors:  V Avdonin; E F Shibata; T Hoshi
Journal:  J Gen Physiol       Date:  1997-02       Impact factor: 4.086

4.  Modulation of transient outward current by extracellular protons and Cd2+ in rat and human ventricular myocytes.

Authors:  M Stengl; E Carmeliet; K Mubagwa; W Flameng
Journal:  J Physiol       Date:  1998-09-15       Impact factor: 5.182

5.  Action of tertiary phenylalkylamines on cardiac transient outward current from outside the cell membrane.

Authors:  J W Wegener; H Nawrath
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-12       Impact factor: 3.000

Review 6.  Modulation of the QT interval duration in hypertension with antihypertensive treatment.

Authors:  Jan Klimas; Peter Kruzliak; Simon W Rabkin
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

7.  Regional alterations of repolarizing K+ currents among the left ventricular free wall of rats with ascending aortic stenosis.

Authors:  T Volk; T H Nguyen; J H Schultz; J Faulhaber; H Ehmke
Journal:  J Physiol       Date:  2001-02-01       Impact factor: 5.182

8.  Larger transient outward K(+) current and shorter action potential duration in Galpha(11) mutant mice.

Authors:  Michael Wagner; Elena Rudakova; Vera Schütz; Magdalena Frank; Heimo Ehmke; Tilmann Volk
Journal:  Pflugers Arch       Date:  2009-12-02       Impact factor: 3.657

9.  Dihydropyridine block of voltage-dependent K+ currents in rat dorsal root ganglion neurons.

Authors:  X-L Zhang; M S Gold
Journal:  Neuroscience       Date:  2009-03-13       Impact factor: 3.590

10.  Dihydropyridine Ca2+ channel antagonists and agonists block Kv4.2, Kv4.3 and Kv1.4 K+ channels expressed in HEK293 cells.

Authors:  Noriyuki Hatano; Susumu Ohya; Katsuhiko Muraki; Wayne Giles; Yuji Imaizumi
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.